(19)
(11) EP 1 648 456 A1

(12)

(43) Date of publication:
26.04.2006 Bulletin 2006/17

(21) Application number: 04742001.3

(22) Date of filing: 19.07.2004
(51) International Patent Classification (IPC): 
A61K 31/439(2000.01)
A61K 31/495(1985.01)
A61P 9/06(2000.01)
A61K 31/4995(2000.01)
(86) International application number:
PCT/EP2004/051532
(87) International publication number:
WO 2005/011690 (10.02.2005 Gazette 2005/06)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 21.07.2003 EP 03102243

(71) Applicant: Solvay Pharmaceuticals GmbH
30173 Hannover (DE)

(72) Inventors:
  • CAUTREELS, Werner
    NL-1381 XA Weesp (NL)
  • STEINBORN, Claus
    30938 Burgwedel (DE)
  • STRAUB, Matthias
    30890 Barsinghausen (DE)
  • BECKMANN, Katrin
    30173 Hannover (DE)
  • JANSEN, Johannes Wilhelmus Catherine Maria
    NL-4105 LE Culemborg (NL)

(74) Representative: Gosmann, Martin et al
c/o Solvay Pharmaceuticals GmbH, PH-ZP (IPSI), Hans Böckler Allee 20
30173 Hannover
30173 Hannover (DE)

   


(54) USE OF 3,7-DIAZABICYCLO¬3,3,1|NONANE COMPOUNDS FOR THE TREATMENT AND/OR PROPHYLAXIS OF ARRHYTHMIC EVENTS IN MALE HUMAN PATIENTS